{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:19:23Z","timestamp":1791890363011,"version":"4.3.4"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T00:00:00Z","timestamp":1564531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12889-019-7288-x","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T17:02:52Z","timestamp":1564592572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Support for people who use Anabolic Androgenic Steroids: A Systematic Scoping Review into what they want and what they access"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0771-3524","authenticated-orcid":false,"given":"Orlanda","family":"Harvey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Keen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarete","family":"Parrish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5523-8583","authenticated-orcid":false,"given":"Edwin","family":"van Teijlingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,31]]},"reference":[{"key":"7288_CR1","unstructured":"Lader D (Editor). Drug misuse: findings from the 2015\/16 Crime Survey for England and Wales. Statistical Bulletin 07\/16 [Internet]. 2016. Available from: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/462885\/drug-misuse-1415.pdf"},{"key":"7288_CR2","unstructured":"Advisory Council on the Misuse of Drugs. Consideration of the anabolic steroids [Internet]. Home Office; 2010 [cited 2016 Mar 1]. p. 1\u201350. Available from: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/144122\/anabolic-steroids.pdf"},{"issue":"6","key":"7288_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2014-005275","volume":"4","author":"A Kimerg\u00e5rd","year":"2014","unstructured":"Kimerg\u00e5rd A, McVeigh J. Environments, risk and health harms: a qualitative investigation into the illicit use of anabolic steroids among people using harm reduction services in the UK. BMJ Open. 2014 Jun;4(6):1.","journal-title":"BMJ Open"},{"key":"7288_CR4","volume-title":"Anabolic steroid use in Great Britain: an exploratory investigation. Final report to the Department of Health for England, Scotland and Wales","author":"P Korkia","year":"1993","unstructured":"Korkia P, Stimson G. Anabolic steroid use in Great Britain: an exploratory investigation. Final report to the Department of Health for England, Scotland and Wales. London: The Centre for Research on Drugs and Health Behaviour; 1993."},{"issue":"4","key":"7288_CR5","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1249\/01.mss.0000210194.56834.5d","volume":"38","author":"AB Parkinson","year":"2006","unstructured":"Parkinson AB, Evans NA. Anabolic androgenic steroids: a survey of 500 users. Med Sci Sport Exerc. 2006 Apr;38(4):644\u201351.","journal-title":"Med Sci Sport Exerc"},{"key":"7288_CR6","unstructured":"Begley E, McVeigh J, Hope V. Image and Performance Enhancing Drugs: 2016 National Survey Results. 2017;1(July):1\u201323."},{"issue":"2","key":"7288_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1530\/EJE-15-0080","volume":"173","author":"E Nieschlag","year":"2015","unstructured":"Nieschlag E, Vorona E. Medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions. Eur J Endocrinol. 2015;173(2):47.","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"7288_CR8","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1080\/09687637.2016.1207752","volume":"24","author":"R Rowe","year":"2017","unstructured":"Rowe R, Berger I, Copeland J. \u201cNo pain, no gainz\u201d? Performance and image-enhancing drugs, health effects and information seeking. Drugs Educ Prev Policy. 2017 Oct;24(5):400\u20138.","journal-title":"Drugs Educ Prev Policy."},{"issue":"1","key":"7288_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/0897190002239631","volume":"16","author":"PA Chyka","year":"2003","unstructured":"Chyka PA. Health risks of selected performance-enhancing drugs. J Pharm Pract. 2003 Feb;16(1):37.","journal-title":"J Pharm Pract"},{"issue":"1","key":"7288_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1570159X13666141210222725","volume":"13","author":"D Piacentino","year":"2015","unstructured":"Piacentino D, Kotzalidis G, del Casale A, Aromatario MR, Pomara C, Girardi P, et al. Anabolic-androgenic steroid use and psychopathology in athletes. A Systematic Review Curr Neuropharmacol. 2015;13(1):101\u201321.","journal-title":"A Systematic Review Curr Neuropharmacol"},{"issue":"3","key":"7288_CR11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.drugalcdep.2005.07.003","volume":"81","author":"A Petersson","year":"2006","unstructured":"Petersson A, Garle M, Holmgren P, Druid H, Krantz P, Thiblin I. Toxicological findings and manner of death in autopsied users of anabolic androgenic steroids. Drug Alcohol Depend. 2006 Mar 1;81(3):241\u20139.","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"7288_CR12","doi-asserted-by":"publisher","first-page":"571","DOI":"10.2165\/00023210-200519070-00002","volume":"19","author":"AJ Trenton","year":"2005","unstructured":"Trenton AJ, Currier GW. Behavioural manifestations of anabolic steroid use. CNS Drugs. 2005 May;19(7):571\u201395.","journal-title":"CNS Drugs"},{"issue":"4","key":"7288_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3109\/10401239909147074","volume":"11","author":"I Thiblin","year":"1999","unstructured":"Thiblin I, Runeson B, Rajs J. Anabolic androgenic steroids and suicide. Ann Clin Psychiatry. 1999 Dec 1;11(4):223\u201331.","journal-title":"Ann Clin Psychiatry"},{"key":"7288_CR14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/978-1-4614-3375-0_19","volume-title":"Drug abuse and addiction in medical illness: causes, consequences and treatment","author":"H Pope Jr","year":"2012","unstructured":"Pope H Jr, Kanayama G. Anabolic- androgenic steroids. In: Verster J, Brady K, Galanter M, Conrod P, editors. Drug abuse and addiction in medical illness: causes, consequences and treatment. New York: Springer; 2012. p. 251\u201374."},{"key":"7288_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pscychresns.2016.12.003","volume":"260","author":"J Seitz","year":"2017","unstructured":"Seitz J, Lyall A, Kanayama G, Makris N, Hudson J, Kubicki M, et al. White matter abnormalities in long-term anabolic-androgenic steroid users: a pilot study. Psychiatry Res Neuroimaging Sect. 2017;260:1\u20135.","journal-title":"Psychiatry Res Neuroimaging Sect"},{"key":"7288_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.drugalcdep.2015.04.023","volume":"152","author":"M Kaufman","year":"2015","unstructured":"Kaufman M, Janes A, Hudson J, Brennan B, Kanayama G, Kerrigan A, et al. Brain and cognition abnormalities in long-term anabolic-androgenic steroid users. Drug Alcohol Depend. 2015;152:47\u201356.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"7288_CR17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.biopsych.2016.06.017","volume":"82","author":"A Bj\u00f8rnebekk","year":"2017","unstructured":"Bj\u00f8rnebekk A, Walhovd KB, J\u00f8rstad ML, Due-T\u00f8nnessen P, Hullstein IR, Fjell AM. Structural brain imaging of long-term anabolic-androgenic steroid users and nonusing weightlifters. Biol Psychiatry. 2017 Aug 15;82(4):294\u2013302.","journal-title":"Biol Psychiatry"},{"key":"7288_CR18","doi-asserted-by":"crossref","unstructured":"Sagoe D, McVeigh J, Bj\u00f8rnebekk A, Essilfie M-S, Andreassen C, Pallesen S. Polypharmacy among anabolic-androgenic steroid users: a descriptive metasynthesis. Subst Abus Treat Prev Policy. 2015;10(12).","DOI":"10.1186\/s13011-015-0006-5"},{"issue":"1","key":"7288_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1017\/S0950268814000727","volume":"143","author":"V Hope","year":"2015","unstructured":"Hope V, McVeigh J, Marongiu A, Evans-Brown M, Smith J, Kimergard A. Injection site infections and injuries in men who inject image- and performance-enhancing drugs: prevalence, risks factors, and healthcare seeking. Epidemiol Infect. 2015 Jan;143(1):132\u201340.","journal-title":"Epidemiol Infect"},{"issue":"4","key":"7288_CR20","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1521-0391.2013.12118.x","volume":"23","author":"Harrison G. Pope","year":"2013","unstructured":"Pope JH, Kanayama G, Athey A, Ryan E, Hudson J, Baggish A. The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates. American Journal on Addictions. 2013; p. 371\u20137.","journal-title":"The American Journal on Addictions"},{"issue":"8","key":"7288_CR21","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1592\/phco.31.8.757","volume":"31","author":"EJ Ip","year":"2011","unstructured":"Ip EJ, Barnett MJ, Tenerowicz MJ, Perry PJ. The anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training. Pharmacotherapy. 2011 Aug;31(8):757\u201366.","journal-title":"Pharmacotherapy."},{"issue":"4","key":"7288_CR22","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3109\/14659891.2014.911977","volume":"20","author":"A Kimerg\u00e5rd","year":"2015","unstructured":"Kimerg\u00e5rd A. A qualitative study of anabolic steroid use amongst gym users in the United Kingdom: motives, beliefs and experiences. J Subst Use. 2015 Aug;20(4):288\u201394.","journal-title":"J Subst Use."},{"issue":"1","key":"7288_CR23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1747-597X-9-24","volume":"9","author":"D Sagoe","year":"2014","unstructured":"Sagoe D, Andreassen CS, Pallesen S. The aetiology and trajectory of anabolic-androgenic steroid use initiation: a systematic review and synthesis of qualitative research. Subst Abus Treat Prev Policy. 2014;9(1):24.","journal-title":"Subst Abus Treat Prev Policy"},{"key":"7288_CR24","doi-asserted-by":"publisher","DOI":"10.2307\/j.ctt1t88x6d","volume-title":"Supporting people with alcohol and drug problems: making a difference","author":"S Galvani","year":"2012","unstructured":"Galvani S. Supporting people with alcohol and drug problems: making a difference. Bristol: The Policy Press, University of Bristol; 2012."},{"key":"7288_CR25","volume-title":"Alcohol and other drugs \u2013 essential information for social workers. A BASW pocket guide","author":"T McCarthy","year":"2010","unstructured":"McCarthy T, Galvani S. Alcohol and other drugs \u2013 essential information for social workers. A BASW pocket guide. Luton: University of Bedfordshire; 2010."},{"issue":"1","key":"7288_CR26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/2327-6924.12380","volume":"29","author":"J Peterson","year":"2017","unstructured":"Peterson J, Pearce PF, Ferguson LA, Langford CA. Understanding scoping reviews: definition, purpose, and process. J Am Assoc Nurse Pract. 2017;29(1):12\u20136.","journal-title":"J Am Assoc Nurse Pract"},{"issue":"3","key":"7288_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/XEB.0000000000000050","volume":"13","author":"MDJ Peters","year":"2015","unstructured":"Peters MDJ, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc. 2015;13(3):141\u20136.","journal-title":"Int J Evid Based Healthc"},{"key":"7288_CR28","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","volume":"62","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Methods of systematic reviews and meta-analysis: preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009 Jan 1;62:1006\u201312.","journal-title":"J Clin Epidemiol"},{"key":"7288_CR29","unstructured":"Harvey O, Parrish M, van Teijlingen E, Keen S. Support for people who use anabolic androgenic steroids: an investigation into what they want and what they currently access [Internet]. PROSPERO 2017 CRD42017075199. 2017. Available from: http:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.php?ID=CRD42017075199"},{"key":"7288_CR30","unstructured":"ACMD Secretariat. Image and performance enhancing drugs: evidence gathering day [internet]. 2017. Available from: https:\/\/www.gov.uk\/government\/news\/image-and-performance-enhancing-drugs-public-evidence-gathering-day"},{"key":"7288_CR31","volume-title":"Doing a literature review in health and social care: a practical guide","author":"H Aveyard","year":"2014","unstructured":"Aveyard H. Doing a literature review in health and social care: a practical guide. 3rd ed. Maidenhead: Open University Press; 2014.","edition":"3"},{"key":"7288_CR32","volume-title":"The Internet in Everyday Life","year":"2002","unstructured":"Wellman B, Haythornthwaite C, editors. The Internet in everyday life. Malden, MA: Wiley-Blackwell|; 2002. (Information Age series)."},{"key":"7288_CR33","unstructured":"Dennington V, Finney-Lamb C, Dillon P, Larance B, Vial R, Copeland J, et al. Qualitative field study for users of performance and image enhancing drugs [internet]. Adelaide; 2008. Available from: http:\/\/www.sahealth.sa.gov.au\/wps\/wcm\/connect\/081d98004f788675b259fbc4163822ed\/Monograph+25-DASSA-Feb2013.pdf?MOD=AJPERES&CACHEID=081d98004f788675b259fbc4163822ed"},{"issue":"7","key":"7288_CR34","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"David Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Medicine"},{"key":"7288_CR35","unstructured":"Public Health Resource Unit. The Critical Skills Appraisal Programme: making sense of evidence. [Internet]. Public Health Resource Unit; 2006 [cited 2017 Jun 6]. Available from: https:\/\/casp-uk.net\/"},{"issue":"4","key":"7288_CR36","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/09687630500103622","volume":"12","author":"B Maycock","year":"2005","unstructured":"Maycock B, Howat P. The barriers to illegal anabolic steroid use. Drugs Educ Prev Policy. 2005 Aug;12(4):317\u201325.","journal-title":"Drugs Educ Prev Policy"},{"issue":"6","key":"7288_CR37","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1177\/1359105306069080","volume":"11","author":"S Grogan","year":"2006","unstructured":"Grogan S, Shepherd S, Evans R, Wright S, Hunter G. Experiences of anabolic steroid use: in-depth interviews with men and women body builders. J Health Psychol. 2006 Nov;11(6):845.","journal-title":"J Health Psychol"},{"issue":"24","key":"7288_CR38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1747-597X-3-24","volume":"3","author":"K Sk\u00e5rberg","year":"2008","unstructured":"Sk\u00e5rberg K, Nyberg F, Engstr\u00f6m I. The development of multiple drug use among anabolic-androgenic steroid users: six subjective case reports. Subst Abuse Treat Prev Policy. 2008 Nov 28;3(24):24.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"1","key":"7288_CR39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1477-7517-11-19","volume":"11","author":"Andreas Kimerg\u00e5rd","year":"2014","unstructured":"Kimerg\u00e5rd A, McVeigh J. Variability and dilemmas in harm reduction for anabolic steroid users in the UK: a multi-area interview study. Harm Reduct J 2014 Jul 2;11(1):1\u201323.","journal-title":"Harm Reduction Journal"},{"issue":"9","key":"7288_CR40","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.drugpo.2015.03.002","volume":"26","author":"M-C Hout van","year":"2015","unstructured":"van Hout M-C, Kean J. An exploratory study of image and performance enhancement drug use in a male British south Asian community. Int J Drug Policy. 2015 Sep 1;26(9):860\u20137.","journal-title":"Int J Drug Policy."},{"issue":"4","key":"7288_CR41","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/dar.12363","volume":"35","author":"M Dunn","year":"2016","unstructured":"Dunn M, Henshaw R, McKay FH. Do performance and image enhancing drug users in regional Queensland experience difficulty accessing health services? Drug Alcohol Rev. 2016;35(4):377\u201382.","journal-title":"Drug Alcohol Rev"},{"key":"7288_CR42","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.peh.2016.11.002","volume":"5","author":"S Griffiths","year":"2016","unstructured":"Griffiths S, Henshaw R, McKay FH, Dunn M. Post-cycle therapy for performance and image enhancing drug users: a qualitative investigation. Perform Enhanc Heal. 2016 Nov 9;5:103\u20137.","journal-title":"Perform Enhanc Heal."},{"key":"7288_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.drugpo.2016.11.005","volume":"40","author":"Gisella Hanley Santos","year":"2017","unstructured":"Hanley Santos G, Coomber R. The risk environment of anabolic\u2013androgenic steroid users in the UK: Examining motivations, practices and accounts of use. Int J Drug Policy. 2017 Feb 1;40(New Psychoactive Substances and Human Enhancement Drugs):35\u201343.","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"7288_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-017-0176-8","volume":"14","author":"B Tighe","year":"2017","unstructured":"Tighe B, Dunn M, McKay FH, Piatkowski T. Information sought, information shared: exploring performance and image enhancing drug user-facilitated harm reduction information in online forums. Harm Reduct J. 2017 Jul 21;14(1):1\u20139.","journal-title":"Harm Reduct J"},{"issue":"1","key":"7288_CR45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.peh.2018.02.002","volume":"6","author":"CW Greenway","year":"2018","unstructured":"Greenway CW, Price C. A qualitative study of the motivations for anabolic-androgenic steroid use: the role of muscle dysmorphia and self-esteem in long-term users. Perform Enhanc Heal. 2018 Mar 1;6(1):12\u201320.","journal-title":"Perform Enhanc Heal"},{"key":"7288_CR46","unstructured":"Davids E, Roman N. A systematic review of the relationship between parenting styles and children\u2019s physical activity. Vol. 20, African Journal for Physical Health Education, Recreation and Dance. 2014. 228\u2013246 p."},{"key":"7288_CR47","volume-title":"Proposal: a mixed methods appraisal tool for systematic mixed studies reviews","author":"P Pluye","year":"2011","unstructured":"Pluye P, Robert E, Cargo M, Bartlett G, O\u2019Cathain A, Griffiths F, et al. Proposal: a mixed methods appraisal tool for systematic mixed studies reviews. Montreal: Department of Family Medicine, McGill University; 2011."},{"issue":"5","key":"7288_CR48","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3109\/16066359.2016.1149570","volume":"24","author":"B Johnson","year":"2016","unstructured":"Johnson B, Richert T. A comparison of privileged access interviewing and traditional interviewing methods when studying drug users in treatment. Addict Res Theory. 2016;24(5):406\u201315.","journal-title":"Addict Res Theory"},{"issue":"1","key":"7288_CR49","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2174\/1874387000802010075","volume":"2","author":"O Al-Falasi","year":"2009","unstructured":"Al-Falasi O, Al-Dahmani K, Al-Eisaei K, Al-Ameri S, Al-Maskari F, Nagelkerke N, et al. Knowledge, attitude and practice of anabolic steroids use among gym users in Al-Ain District, United Arab Emirates. Open Sport Med J. 2009;2(1):75\u201381.","journal-title":"Open Sport Med J"},{"issue":"6","key":"7288_CR50","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1600-0838.2009.01023.x","volume":"20","author":"J Bojsen-M\u00f8ller","year":"2010","unstructured":"Bojsen-M\u00f8ller J, Christiansen A. Use of performance- and image-enhancing substances among recreational athletes: a quantitative analysis of inquiries submitted to the Danish anti-doping authorities. Scand J Med Sci Sports. 2010 Dec;20(6):861\u20137.","journal-title":"Scand J Med Sci Sports"},{"key":"7288_CR51","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.drugpo.2017.05.048","volume":"46","author":"B Jacka","year":"2017","unstructured":"Jacka B, Peacock A, Degenhardt L, Bruno R, Clare P, Kemp R, et al. Trends in PIEDs use among male clients of needle-syringe programs in Queensland, Australia; 2007-2015. Int J Drug Policy. 2017 Aug;46:74\u20138.","journal-title":"Int J Drug Policy."},{"issue":"6","key":"7288_CR52","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1080\/09595230802392568","volume":"27","author":"B Larance","year":"2008","unstructured":"Larance B, Degenhardt L, Copeland J, Dillon P. Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs. Drug Alcohol Rev. 2008 Nov;27(6):679\u201386.","journal-title":"Drug Alcohol Rev."},{"issue":"9","key":"7288_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2013-003207","volume":"3","author":"V Hope","year":"2013","unstructured":"Hope V, McVeigh J, Marongiu A, Evans-Brown M, Smith J, Kimerg\u00e5rd A, et al. Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: a cross-sectional study. BMJ Open. 2013 Sep;3(9):1.","journal-title":"BMJ Open"},{"issue":"9","key":"7288_CR54","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.drugpo.2015.05.009","volume":"26","author":"I Beek van","year":"2015","unstructured":"van Beek I, Chronister KJK. Performance and image enhancing drug injectors\u2019 access to needle syringe programs: responding to a public policy dilemma. Int J Drug Policy. 2015 Sep 1;26(9):868\u201374.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"7288_CR55","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/0091450917694268","volume":"44","author":"R Zahnow","year":"2017","unstructured":"Zahnow R, McVeigh J, Ferris J, Winstock A. Adverse effects, health service engagement, and service satisfaction among anabolic androgenic steroid users. Contemp Drug Probl. 2017 Mar;44(1):69\u201383.","journal-title":"Contemp Drug Probl"},{"issue":"1","key":"7288_CR56","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1748-5908-5-69","volume":"5","author":"D Levac","year":"2010","unstructured":"Levac D, Colquhoun H, O\u2019Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010;5(1):69.","journal-title":"Implement Sci"},{"key":"7288_CR57","volume-title":"Risk and blood-borne virus testing among men who inject image and performance enhancing drugs","author":"R Rowe","year":"2017","unstructured":"Rowe R, Berger I, Yaseen B, Copeland J. Risk and blood-borne virus testing among men who inject image and performance enhancing drugs. Australia. Drug Alcohol Rev: Sydney; 2017 Feb 28."},{"issue":"1","key":"7288_CR58","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1550-2783-4-12","volume":"4","author":"J Cohen","year":"2007","unstructured":"Cohen J, Collins R, Darkes J, Gwartney D. A league of their own: demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States. J Int Soc Sports Nutr. 2007;4(1):12.","journal-title":"J Int Soc Sports Nutr"},{"key":"7288_CR59","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.drugpo.2018.02.022","volume":"55","author":"R Zahnow","year":"2018","unstructured":"Zahnow R, McVeigh J, Bates G, Hope V, Kean J, Campbell J, et al. Identifying a typology of men who use anabolic androgenic steroids (AAS). Int J Drug Policy. 2018 May 1;55:105\u201312.","journal-title":"Int J Drug Policy."},{"issue":"1","key":"7288_CR60","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/dar.12085","volume":"33","author":"M Dunn","year":"2014","unstructured":"Dunn M, McKay FH, Iversen J. Steroid users and the unique challenge they pose to needle and syringe program workers. Drug Alcohol Rev. 2014;33(1):71\u20137.","journal-title":"Drug Alcohol Rev."},{"key":"7288_CR61","volume-title":"Doing your literature review: traditional and systematic techniques","author":"J Jesson","year":"2011","unstructured":"Jesson J, Matheson L, Lacey F. Doing your literature review: traditional and systematic techniques. London: SAGE; 2011."},{"issue":"4","key":"7288_CR62","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.bodyim.2013.07.009","volume":"10","author":"R Galioto","year":"2013","unstructured":"Galioto R, Crowther JH. The effects of exposure to slender and muscular images on male body dissatisfaction. Body Image. 2013;10(4):566\u201373.","journal-title":"Body Image."},{"key":"7288_CR63","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.chb.2014.04.029","volume":"37","author":"Z Sylvia","year":"2014","unstructured":"Sylvia Z, King TK, Morse BJ. Virtual ideals: the effect of video game play on male body image. Comput Human Behav. 2014;37:183\u20138.","journal-title":"Comput Human Behav"},{"key":"7288_CR64","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.eatbeh.2015.04.004","volume":"18","author":"AY Jesus De","year":"2015","unstructured":"De Jesus AY, Ricciardelli LA, Fris\u00e9n A, Smolak L, Yager Z, Fuller-Tyszkiewicz M, et al. Media internalization and conformity to traditional masculine norms in relation to body image concerns among men. Eat Behav. 2015;18:137\u201342.","journal-title":"Eat Behav"},{"issue":"2","key":"7288_CR65","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1080\/15332560802156984","volume":"8","author":"A Bardick","year":"2008","unstructured":"Bardick A, Nixon G, Bernes K. More than meets the eye: weight lifting and steroid use in men. J Soc Work Pract Addict. 2008 Jun;8(2):208\u201327.","journal-title":"J Soc Work Pract Addict"},{"issue":"1","key":"7288_CR66","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bodyim.2009.08.003","volume":"7","author":"S Daniel","year":"2010","unstructured":"Daniel S, Bridges SK. The drive for muscularity in men: media influences and objectification theory. Body Image. 2010;7(1):32\u20138.","journal-title":"Body Image"},{"key":"7288_CR67","doi-asserted-by":"crossref","unstructured":"Taylor LD, Fortaleza J. media Violence and Male Body Image. Psychol Men Masc. 2016;(January).","DOI":"10.1037\/men0000030"},{"key":"7288_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09687637.2016.1277983","volume":"25","author":"G Bates","year":"2018","unstructured":"Bates G, Tod D, Leavey C, McVeigh J. An evidence-based socioecological framework to understand men\u2019s use of anabolic androgenic steroids and inform interventions in this area. Drugs Educ Prev Policy. 2018 Jul;25:1\u20139.","journal-title":"Drugs Educ Prev Policy."},{"issue":"12","key":"7288_CR69","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1111\/j.1360-0443.2009.02734.x","volume":"104","author":"G Kanayama","year":"2009","unstructured":"Kanayama G, Brower K, Wood R, Hudson J, Pope JH. Anabolic-androgenic steroid dependence: an emerging disorder. Addiction. 2009;104(12):1966\u201378.","journal-title":"Addiction."},{"issue":"2","key":"7288_CR70","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1016\/j.jadohealth.2015.10.217","volume":"58","author":"CE Guss","year":"2016","unstructured":"Guss CE, Williams DN, Reisner SL, Austin SB, Katz-Wise SL. Disordered weight management behaviors and non-prescription steroid use in Massachusetts transgender youth. J Adolesc Health. 2016;58(2):S102\u20133.","journal-title":"J Adolesc Health"},{"key":"7288_CR71","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00213-015-4193-6","volume":"233","author":"M Onakomaiya","year":"2016","unstructured":"Onakomaiya M, Henderson L. Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviors. Psychopharmacology. 2016;233:549\u201369.","journal-title":"Psychopharmacology"},{"issue":"2","key":"7288_CR72","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1521-0391.2013.00311.x","volume":"22","author":"B Brennan","year":"2013","unstructured":"Brennan B, Kanayama G, Pope JH. Performance-enhancing drugs on the web: a growing public-health issue. Am J Addict. 2013 Mar;22(2):158\u201361.","journal-title":"Am J Addict"},{"key":"7288_CR73","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bodyim.2015.10.002","volume":"16","author":"S Murray","year":"2016","unstructured":"Murray S, Griffiths S, Hazery L, Shen T, Wooldridge T, Mond J. Go big or go home: a thematic content analysis of pro-muscularity websites. Body Image. 2016 Mar;16:17\u201320.","journal-title":"Body Image."},{"issue":"6","key":"7288_CR74","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1177\/1477370816633261","volume":"13","author":"G Antonopoulos","year":"2016","unstructured":"Antonopoulos G, Hall A. \u2018Gain with no pain\u2019: anabolic-androgenic steroids trafficking in the UK. Eur J Criminol. 2016 Nov;13(6):696\u2013713.","journal-title":"Eur J Criminol"},{"key":"7288_CR75","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/17430437.2015.1096246","volume":"19","author":"J Andreasson","year":"2016","unstructured":"Andreasson J, Johansson T. Online doping. The new self-help culture of ethnopharmacology. Sport Soc. 2016 Sep;19:7\u2013957.","journal-title":"Sport Soc"},{"issue":"5","key":"7288_CR76","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1111\/hsc.12326","volume":"25","author":"R Brennan","year":"2017","unstructured":"Brennan R, Wells J, van Hout M-C. The injecting use of image and performance-enhancing drugs (IPED) in the general population: a systematic review. Health Soc Care Community. 2017 Sep;25(5):1459\u2013531.","journal-title":"Health Soc Care Community"},{"issue":"1\u20132","key":"7288_CR77","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.drugalcdep.2010.04.008","volume":"111","author":"A Petersson","year":"2010","unstructured":"Petersson A, Bengtsson J, Voltaire-Carlsson A, Thiblin I. Substance abusers\u2019 motives for using anabolic androgenic steroids. Drug Alcohol Depend. 2010;111(1\u20132):170\u20132.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"7288_CR78","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.drugpo.2007.09.002","volume":"20","author":"L Simmonds","year":"2009","unstructured":"Simmonds L, Coomber R. Injecting drug users: a stigmatised and stigmatising population. Int J Drug Policy. 2009 Mar;20(2):121\u201330.","journal-title":"Int J Drug Policy."},{"issue":"4","key":"7288_CR79","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s00213-002-1352-3","volume":"166","author":"J Cole","year":"2003","unstructured":"Cole J, Smith R, Halford J, Wagstaff G. A preliminary investigation into the relationship between anabolic-androgenic steroid use and the symptoms of reverse anorexia in both current and ex-users. Psychopharmacology. 2003 Apr;166(4):424\u20139.","journal-title":"Psychopharmacology"},{"key":"7288_CR80","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders: DSM 5","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM 5. 5th ed. Washington, D.C.: APA; 2013.","edition":"5"},{"issue":"2","key":"7288_CR81","first-page":"210","volume":"21","author":"H Joubert","year":"2016","unstructured":"Joubert H, Melluish S. Considering anabolic androgenic steroid use in relation to non-substance related diagnostic categories with special emphasis on eating disorders: a systematic review. J Subst Use. 2016 Apr;21(2):210.","journal-title":"J Subst Use"},{"issue":"3","key":"7288_CR82","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1080\/10413200903019376","volume":"21","author":"V Ebbeck","year":"2009","unstructured":"Ebbeck V, Lou WP, Concepcion RY, Cardinal BJ, Hammermeister J. Muscle dysmorphia symptoms and their relationships to self-concept and negative affect among college recreational exercisers. J Appl Sport Psychol. 2009;21(3):262\u201375.","journal-title":"J Appl Sport Psychol"},{"issue":"3","key":"7288_CR83","first-page":"295","volume":"24","author":"Ask Vest Christiansen","year":"2016","unstructured":"Christiansen A, Vinther A, Liokaftos D. Outline of a typology of men\u2019s use of anabolic androgenic steroids in fitness and strength training environments. Drugs Educ Prev policy. 2016;24:3(April):1\u201311.","journal-title":"Drugs: Education, Prevention and Policy"},{"issue":"3","key":"7288_CR84","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/10640260902848477","volume":"17","author":"L Rohman","year":"2009","unstructured":"Rohman L. The relationship between anabolic androgenic steroids and muscle dysmorphia: a review. Eat Disord. 2009;17(3):187\u201399.","journal-title":"Eat Disord"},{"key":"7288_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bodyim.2017.04.003","volume":"22","author":"L Mitchell","year":"2017","unstructured":"Mitchell L, Murray SB, Hoon M, Hackett D, Prvan T, O\u2019Connor H. Correlates of muscle dysmorphia symptomatology in natural bodybuilders: distinguishing factors in the pursuit of hyper-muscularity. Body Image. 2017;22:1\u20135.","journal-title":"Body Image."},{"issue":"4","key":"7288_CR86","first-page":"352","volume":"40","author":"J Leone","year":"2005","unstructured":"Leone J, Sedory E, Gray K. Recognition and treatment of muscle dysmorphia and related body image disorders. J Athl Train. 2005 Oct;40(4):352\u20139.","journal-title":"J Athl Train"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-019-7288-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-019-7288-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-019-7288-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T16:40:53Z","timestamp":1610728853000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-019-7288-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,31]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["7288"],"URL":"https:\/\/doi.org\/10.1186\/s12889-019-7288-x","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,31]]},"assertion":[{"value":"15 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1024"}}